VT
Vitrolife AB (publ)
VTRLY · OTC
$9.50 +0.00% (+$0.00)
Market Cap 12.6B kr
P/E Ratio -
Div. Yield 1.24%
ROE 53.34%
Bulios Fair Price
$8.65
8.9% downside
Trenutna cena
$9.5
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VTRLY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
69 /100
Cheap P/B 1.55x
P/FCF 20.78x
P/S 3.72x
Growth
15 /100
Declining FCF growth 14.50%
Book val. growth 22.16%
Rev. growth 2.08%
Profitability
50 /100
Moderate Net margin 147.49%
Op. margin 141.11%
FCF margin 17.92%
Quality
4 /100
Poor ROE 53.34%
ROA 44.08%
Asset turnover 0.30x
Debt
69 /100
Low Current ratio 3.64x
Int. coverage -127.26x
Debt/Equity 0.20x
Stability
35 /100
Moderate Rev. volatility 6.66%
EPS volatility 671.56%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VTRLY
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Bronwyn Brophy O'Connor
Employees
1,151
Headquarters
Gothenburg